Influence of NK cell count on the survival of patients with diffuse large B-cell lymphoma treated with R-CHOP

BACKGROUND: Although adding rituximab to the chemotherapy regimen of cyclophosphamide, vincristine, doxorubicin, and prednisone (R-CHOP) has improved clinical outcomes of patients with diffuse large B-cell lymphoma (DLBCL), several recent studies have shown that the effect of rituximab is dominantly...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Joong-Keun, Chung, Joo-Seop, Shin, Ho-Jin, Song, Moo-Kon, Yi, Ji-Won, Shin, Dong-Hun, Lee, Dae-Sung, Baek, Sung-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188781/
https://www.ncbi.nlm.nih.gov/pubmed/25325035
http://dx.doi.org/10.5045/br.2014.49.3.162

Ejemplares similares

Ejemplares similares